These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

963 related articles for article (PubMed ID: 16563815)

  • 41. The platelet-vessel wall interaction in experimental atherosclerosis and ischaemic heart disease with special reference to thrombopoiesis.
    Kristensen SD
    Dan Med Bull; 1992 Apr; 39(2):110-27. PubMed ID: 1611918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Platelet hyperaggregation induced by an antiplatelet monoclonal antibody in a female patient with essential thrombocythemia of childhood].
    Perutelli P; Biglino P; Molinari AC; Boeri E; Mori PG
    Recenti Prog Med; 1992 Dec; 83(12):688-9. PubMed ID: 1494708
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelets in thrombotic disorders: quantitative and qualitative platelet disorders predisposing to arterial thrombosis.
    Harker LA
    Semin Hematol; 1998 Jul; 35(3):241-52. PubMed ID: 9685170
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of platelet and white blood cell counts on major thrombosis - analysis from a patient registry in essential thrombocythemia.
    Buxhofer-Ausch V; Steurer M; Sormann S; Schloegl E; Schimetta W; Gisslinger B; Ruckser R; Gastl G; Gisslinger H
    Eur J Haematol; 2016 Dec; 97(6):511-516. PubMed ID: 27037858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Congenital disorders associated with platelet dysfunctions.
    Nurden P; Nurden AT
    Thromb Haemost; 2008 Feb; 99(2):253-63. PubMed ID: 18278172
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemia.
    Buxhofer-Ausch V; Wolf D; Sormann S; Forjan E; Schimetta W; Gisslinger B; Heibl S; Krauth MT; Thiele J; Ruckser R; Gisslinger H
    Eur J Haematol; 2021 Jan; 106(1):58-63. PubMed ID: 32909297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Essential thrombocythemia: a hypercoagulable state.
    Hunter Mellado RF; Oppenheimer Catalá J; Vázquez Medina J
    Bol Asoc Med P R; 1991 Oct; 83(10):436-9. PubMed ID: 1789889
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genetic strain differences in platelet aggregation and thrombus formation of laboratory rats.
    Sudo T; Ito H; Hayashi H; Nagamura Y; Toga K; Yamada Y
    Thromb Haemost; 2007 Apr; 97(4):665-72. PubMed ID: 17393031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contact-dependent signaling events that promote thrombus formation.
    Brass LF; Jiang H; Wu J; Stalker TJ; Zhu L
    Blood Cells Mol Dis; 2006; 36(2):157-61. PubMed ID: 16473534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Arterial stenosis and atherothrombotic events in polycythemia vera and essential thrombocythemia.
    Cucuianu A; Stoia M; Farcaş A; Dima D; Zdrenghea M; Paţiu M; Olinic D; Petrov L
    Rom J Intern Med; 2006; 44(4):397-406. PubMed ID: 18386616
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PRV-1, erythroid colonies and platelet Mpl are unrelated to thrombosis in essential thrombocythaemia.
    Vannucchi AM; Grossi A; Pancrazzi A; Antonioli E; Guglielmelli P; Balestri F; Biscardi M; Bulgarelli S; Longo G; Graziano C; Gugliotta L; Bosi A
    Br J Haematol; 2004 Oct; 127(2):214-9. PubMed ID: 15461629
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aspirin-resistant platelet aggregation in a cohort of patients with coronary heart disease.
    Pamukcu B; Oflaz H; Onur I; Oncul A; Umman B; Koylan N; Bugra Z; Meric M; Nisanci Y
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):461-5. PubMed ID: 17581321
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is primary haemostasis controlled by a 'platelet delay time'? Formulation of a new hypothesis.
    Kratzer MA
    Platelets; 2003; 14(7-8):437-43. PubMed ID: 14713513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The gray platelet syndrome: clinical spectrum of the disease.
    Nurden AT; Nurden P
    Blood Rev; 2007 Jan; 21(1):21-36. PubMed ID: 16442192
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between hemostatic markers and platelet indices in patients with aortic aneurysm.
    Ihara A; Matsumoto K; Kawamoto T; Shouno S; Kawamoto J; Katayama A; Yoshitatsu M; Izutani H
    Pathophysiol Haemost Thromb; 2006; 35(6):451-6. PubMed ID: 17565239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet structural physiology: the ultrastructure of adhesion, secretion, and aggregation in arterial thrombosis.
    White JG
    Cardiovasc Clin; 1987; 18(1):13-33. PubMed ID: 3607810
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Arterial thromboses and essential thrombocythemia in young patients].
    Decoulx E; Millaire A; Jude B; Marquand A; Tison E; Bauters F; Ducloux G
    Ann Cardiol Angeiol (Paris); 1990 Jun; 39(6):347-50. PubMed ID: 2400197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Platelet dysplasia associated with megakaryoblastic leukemia in a dog.
    Cain GR; Feldman BF; Kawakami TG; Jain NC
    J Am Vet Med Assoc; 1986 Mar; 188(5):529-30. PubMed ID: 3514560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.